Scientists at the University of Southampton have uncovered how the immune system’s natural killer cells can target a protein known as XPO1, which promotes cancer. By hijacking this protein, they may activate more killer cells to destroy cancer cells. This discovery could lead to new, less invasive cancer treatments, showing promise for personalized immunotherapy.